Wanneer medicijnen en games samenkomen door Tom Aelbrecht (Zorgidee 2013)

Post on 07-May-2015

1.939 views 3 download

description

Het traditionele business model van de big pharma werkt allang niet meer. Janssen Pharmaceutica zoekt dan ook naar succesvolle formules om te innoveren. Eén van de innovatietrajecten dat alvast veelbelovend is, is Serious Gaming. Tom Aelbrecht, directeur van het incubatiecentrum van het Venture & Incubationcenter van Janssen, neemt ons mee doorheen het innovatietraject en laat ons zien waarom zij misschien zelfs meer geloven in de toekomst van games dan die van pillen.

Transcript of Wanneer medicijnen en games samenkomen door Tom Aelbrecht (Zorgidee 2013)

Medicines & Games

Janssen Pharmaceutica NV

Director Venture & Incubation Center

Tom Aelbrecht

Janssen Proprietary & Confidential

Today it is estimated that Alzheimer's disease affects about 26 million people worldwide. With an increasing aged population, that number is expected to be four

times that of today by 2050.

(Source: Alzheimer Europe)

2

Janssen Proprietary & Confidential

In 2007, 33.2 million people were estimated to be living with HIV/AIDS, 2.5 million people became newly infected and 2.1 million people died of HIV/AIDS.

(Source: World Health Organization)

3

Janssen Proprietary & Confidential

Cancer in Europe affects 1 in 3 men and 1 in 4 women at some time in their lives. It is estimated that 1,2 million EU citizens die from cancer each year which kills

about one in four people in Europe.

(Source: Public Health Portal of the European Union)

4

Janssen Proprietary & Confidential

There are approximately 170 million people chronically infected with hepatitis C worldwide.

5

Janssen Proprietary & Confidential

Each year Cardiovascular Disease (CVD) causes over 4.3 million deaths in Europe. Overall CVD is estimated to cost the EU economy

€192 billion a year.

(Source: European Heart Network)

6

Janssen Proprietary & Confidential

Diabetes currently affects 246 million people worlwide and is expected to affect 380 million by 2025. Each year 3.8 million deaths are attributable to diabetes.

(Source: International Diabetes Foundation)

7

Janssen Proprietary & Confidential

Caring for the world, one person

at a time…

… inspires and unites the people

of Johnson & Johnson.

8

Janssen Proprietary & Confidential

We embrace research and science

− bringing innovative ideas,

products and services to advance

the health and well-being of

people.

9

Janssen Proprietary & Confidential

Quiz

What’s the average time required to develop a medicine?

What’s the average cost associated with developing a drug?

How’s the pharmaceutical industry rated in the overall industry image poll?

10

Janssen Proprietary & Confidential

A new era of healthcare

11

FUTURE MODEL

Towards sustainableintegrated

consumer centrichealthcare solutions

New Healthcare modelsWhat do we offer as solution?

New Business modelsHow do we create value for

every one?

New Collaboration modelsHow do we get there

and with whom?

Need for:

Janssen Proprietary & Confidential

Our mission and vision

We are driven by the care for our patients – our goal is to create, develop and deliver ground-breaking therapeutic solutions that will make a difference.

Therefore, we build an open entrepreneurial community in which we, as a center of innovation, focus together on activities with a high added value.

12

Janssen Proprietary & Confidential

Approach – Incubation & Acceleration

16/12/2011 13

HealSeekerSerious gaming for children with ADHD

Janssen Proprietary & Confidential 11/02/2013 15

Janssen Proprietary & Confidential 11/02/2013

16

HealSeeker

A Serious Game developed bydomain specialists for children

with ADHD to train on

time management,

planning & organization

social behaviour

Janssen Proprietary & Confidential 11/02/2013 17

Our ambitionValidate and launch

a serious game in 2013 which will improve people’s live

Janssen Proprietary & Confidential

janssencampusbe@its.jnj.com

+32 14 60 31 89

Who to contact?

18